Page last updated: 2024-08-24

valsartan and Angioedema

valsartan has been researched along with Angioedema in 23 studies

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (21.74)29.6817
2010's14 (60.87)24.3611
2020's4 (17.39)2.80

Authors

AuthorsStudies
Bedhomme, S; Bouchant, S; Boussageon, R; Bœuf-Gibot, S; Charuel, E; Menini, T; Pereira, B; Piñol-Domenech, N; Vaillant-Roussel, H1
Anand, IS; Boytsov, SA; Claggett, B; Cleland, J; Comin-Colet, J; Desai, AS; Düngen, HD; Ge, J; Goncalvesova, E; Gong, J; Jhund, PS; Katova, T; Kerr Saraiva, JF; Lam, CSP; Lefkowitz, MP; Lelonek, M; Maggioni, AP; Martinez, F; McMurray, JJV; Merkely, B; Packer, M; Pfeffer, MA; Pieske, B; Redfield, MM; Rizkala, AR; Rouleau, JL; Senni, M; Shah, SJ; Shi, VC; Solomon, SD; van Veldhuisen, DJ; Zannad, F; Zhou, J; Zile, MR1
Dani, SS; Ganatra, S; Vaduganathan, M1
Caldeira, D; Costa, J; David, C; Ferreira, JJ; Katerenchuk, V; Martins E Pereira, G; Pinto, FJ; S Duarte, G1
Brar, S; D'Albo, N; Dani, SS; Dey, A; Ganatra, S; Kim, YS; Shah, S1
Chrysant, SG1
Barbera, V; Bellasi, A; Cozzolino, M; De Pascalis, A; Di Lullo, L; Floccari, F; Mudoni, A; Rivera, R; Ronco, C; Santoro, A; Verdesca, S1
Kaplan, A; Modgill, V; Senni, M; Shi, V; Streefkerk, H; Zhou, W1
Adie, S; Bitar, A; Dorsch, M; Hanigan, S; Koelling, T; Pogue, K1
Baek, SH; Chiang, FT; Gotou, H; Inubushi-Molessa, A; Kario, K; Lefkowitz, M; Sun, N; Supasyndh, O; Zhang, J; Zhang, Y1
Kamimura, R; Kawana, S; Nishisako, R; Urabe, T1
Jacob, MS; Sabe, MA; Taylor, DO1
Brown, NJ; Hubers, SA1
Chapman, RH; Heidenreich, PA; Ollendorf, DA; Pearson, SD; Sandhu, AT1
Brozena, S; Jessup, M; Owens, AT1
Teerlink, JR; Tyler, JM1
Cooley, C; Kalra, A; Palaniswamy, C; Zanotti-Cavazzoni, SL1
Armstrong, SR; Budman, J; Cheruvu, M; Hegde, LG; Hegde, SS; Hill, CM; Klein, U; Lane, CE; Olsufka, R; Park, T; Renner, T; Sandvik, ER; Thibodeaux, H; Yu, C1
Domínguez Ortega, FJ; Fuentes Gonzalo, MJ; Martínez Alonso, JC; Méndez Alcalde, J1
Bork, K; Dewald, G1
Arakawa, M; Murata, Y; Rikimaru, Y; Sasaki, Y1
de la Serna Higuera, C1
Vidt, DG1

Reviews

10 review(s) available for valsartan and Angioedema

ArticleYear
Benefits and adverse effects of sacubitril/valsartan in patients with chronic heart failure: A systematic review and meta-analysis.
    Pharmacology research & perspectives, 2021, Volume: 9, Issue:5

    Topics: Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Biphenyl Compounds; Chronic Disease; Drug Combinations; Heart Failure; Hospitalization; Humans; Hyperkalemia; Hypotension; Mortality; Renal Insufficiency; Risk Assessment; Stroke Volume; Valsartan

2021
Angioedema with sacubitril/valsartan: Trial-level meta-analysis of over 14,000 patients and real-world evidence to date.
    International journal of cardiology, 2021, 01-15, Volume: 323

    Topics: Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Biphenyl Compounds; Drug Combinations; Heart Failure; Humans; Stroke Volume; Tetrazoles; Valsartan

2021
Safety and tolerability of sacubitril-valsartan: a systematic review and meta-analysis.
    Expert opinion on drug safety, 2021, Volume: 20, Issue:5

    Topics: Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Biphenyl Compounds; Drug Combinations; Humans; Hypotension; Randomized Controlled Trials as Topic; Risk; Tetrazoles; Valsartan

2021
Five Years of Sacubitril/Valsartan-a Safety Analysis of Randomized Clinical Trials and Real-World Pharmacovigilance.
    Cardiovascular drugs and therapy, 2022, Volume: 36, Issue:5

    Topics: Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Drug Combinations; Heart Failure; Humans; Hyperkalemia; Hypotension; Kidney Diseases; Pharmacovigilance; Randomized Controlled Trials as Topic; Stroke Volume; Tetrazoles; Treatment Outcome; Valsartan

2022
Pharmacokinetic, pharmacodynamic, and antihypertensive effects of the neprilysin inhibitor LCZ-696: sacubitril/valsartan.
    Journal of the American Society of Hypertension : JASH, 2017, Volume: 11, Issue:7

    Topics: Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Antihypertensive Agents; Atrial Natriuretic Factor; Biphenyl Compounds; Clinical Trials as Topic; Cough; Cyclic GMP; Diuresis; Drug Combinations; Heart Failure; Heart Ventricles; Humans; Hypertension; Natriuretic Peptide, Brain; Neprilysin; Peptide Fragments; Renin-Angiotensin System; Stroke Volume; Tetrazoles; Valsartan; Vasodilation

2017
[Neprilysin inhibition and chronic kidney disease].
    Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2017, Sep-28, Volume: 34, Issue:5

    Topics: Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Cardiovascular Diseases; Clinical Trials as Topic; Disease Progression; Diuresis; Drug Combinations; Heart Failure; Humans; Hypertension; Kidney Failure, Chronic; Models, Biological; Molecular Targeted Therapy; Natriuresis; Natriuretic Peptides; Neprilysin; Proteinuria; Renal Insufficiency, Chronic; Renin-Angiotensin System; Tetrazoles; Valsartan

2017
Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.
    Circulation, 2016, Mar-15, Volume: 133, Issue:11

    Topics: Abnormalities, Drug-Induced; Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Biphenyl Compounds; Bradykinin; Contraindications; Drug Combinations; Drug Costs; Drug Synergism; Enalapril; Enzyme Inhibitors; Female; Follow-Up Studies; Heart Failure; Humans; Hyperkalemia; Hypertension; Kidney; Multicenter Studies as Topic; Natriuretic Peptides; Neprilysin; Pregnancy; Prodrugs; Prospective Studies; Pyridines; Randomized Controlled Trials as Topic; Stroke Volume; Tetrazoles; Thiazepines; Valsartan

2016
Neprilysin Inhibitors: Emerging Therapy for Heart Failure.
    Annual review of medicine, 2017, 01-14, Volume: 68

    Topics: Alzheimer Disease; Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Drug Combinations; Heart Failure; Humans; Neprilysin; Patient Selection; Pyridines; Stroke Volume; Tetrazoles; Thiazepines; Valsartan

2017
The safety of sacubitril-valsartan for the treatment of chronic heart failure.
    Expert opinion on drug safety, 2017, Volume: 16, Issue:2

    Topics: Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Chronic Disease; Drug Combinations; Enalapril; Heart Failure; Humans; Risk Factors; Tetrazoles; Valsartan

2017
Valsartan-induced angioedema in a patient on angiotensin-converting enzyme inhibitor for years: case report and literature review.
    American journal of therapeutics, 2012, Volume: 19, Issue:6

    Topics: Aged, 80 and over; Angioedema; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Female; Humans; Hypertension; Tetrazoles; Time Factors; Valine; Valsartan

2012

Trials

4 trial(s) available for valsartan and Angioedema

ArticleYear
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
    The New England journal of medicine, 2019, 10-24, Volume: 381, Issue:17

    Topics: Aged; Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Biphenyl Compounds; Cardiovascular Diseases; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Hypotension; Male; Middle Aged; Neprilysin; Quality of Life; Sex Factors; Single-Blind Method; Stroke Volume; Tetrazoles; Valsartan

2019
Angioedema in heart failure patients treated with sacubitril/valsartan (LCZ696) or enalapril in the PARADIGM-HF study.
    International journal of cardiology, 2018, 08-01, Volume: 264

    Topics: Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Allergic Agents; Biphenyl Compounds; Double-Blind Method; Drug Combinations; Enalapril; Female; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Risk Assessment; Stroke Volume; Tetrazoles; Treatment Outcome; Valsartan

2018
Efficacy and safety of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Asian patients with hypertension: a randomized, double-blind, placebo-controlled study.
    Hypertension (Dallas, Tex. : 1979), 2014, Volume: 63, Issue:4

    Topics: Aged; Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Asian People; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; China; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Incidence; Japan; Male; Middle Aged; Neprilysin; Republic of Korea; Taiwan; Tetrazoles; Thailand; Treatment Outcome; Valsartan

2014
A new class of drugs for systolic heart failure: The PARADIGM-HF study.
    Cleveland Clinic journal of medicine, 2015, Volume: 82, Issue:10

    Topics: Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Biphenyl Compounds; Cardiovascular Diseases; Cough; Double-Blind Method; Drug Combinations; Enalapril; Female; Heart Failure, Systolic; Hospitalization; Humans; Hyperkalemia; Hypotension; Male; Middle Aged; Neprilysin; Renal Insufficiency; Tetrazoles; Valsartan

2015

Other Studies

9 other study(ies) available for valsartan and Angioedema

ArticleYear
Real-World Prevalence of Adverse Events After Initiating Sacubitril/Valsartan Compared With Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Systolic Heart Failure.
    Journal of cardiac failure, 2019, Volume: 25, Issue:5

    Topics: Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Cohort Studies; Drug Combinations; Female; Glomerular Filtration Rate; Heart Failure, Systolic; Humans; Hyperkalemia; Hypotension; Male; Middle Aged; Retrospective Studies; Tetrazoles; Valsartan

2019
[Case of drug-induced angioedema (DIAE) on induction of anesthesia with difficult ventilation due to oropharyngeal edema].
    Masui. The Japanese journal of anesthesiology, 2014, Volume: 63, Issue:4

    Topics: Aged; Anesthesia, Epidural; Anesthesia, General; Angioedema; Angiotensin Receptor Antagonists; Edema; Humans; Intubation, Intratracheal; Male; Pharyngeal Diseases; Prostatectomy; Prostatic Neoplasms; Severity of Illness Index; Tetrazoles; Valine; Valsartan

2014
Cost-Effectiveness of Sacubitril-Valsartan in Patients With Heart Failure With Reduced Ejection Fraction.
    Annals of internal medicine, 2016, Nov-15, Volume: 165, Issue:10

    Topics: Aminobutyrates; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Cost-Benefit Analysis; Drug Combinations; Heart Failure; Hospitalization; Humans; Lisinopril; Markov Chains; Middle Aged; Quality-Adjusted Life Years; Stroke Volume; Tetrazoles; Treatment Outcome; Valsartan

2016
Concomitant angiotensin AT1 receptor antagonism and neprilysin inhibition produces omapatrilat-like antihypertensive effects without promoting tracheal plasma extravasation in the rat.
    Journal of cardiovascular pharmacology, 2011, Volume: 57, Issue:4

    Topics: Angioedema; Animals; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Indans; Male; Neprilysin; Propionates; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Thiazepines; Valine; Valsartan

2011
Angioedema due to valsartan.
    Allergy, 2003, Volume: 58, Issue:4

    Topics: Aged; Angioedema; Angiotensin Receptor Antagonists; Antihypertensive Agents; Female; Humans; Tetrazoles; Valine; Valsartan

2003
Hereditary angioedema type III, angioedema associated with angiotensin II receptor antagonists, and female sex.
    The American journal of medicine, 2004, May-01, Volume: 116, Issue:9

    Topics: Aged; Angioedema; Angiotensin Receptor Antagonists; Antihypertensive Agents; Female; Humans; Losartan; Sex Factors; Tetrazoles; Valine; Valsartan

2004
Drug-induced isolated visceral angioneurotic edema.
    Internal medicine (Tokyo, Japan), 2005, Volume: 44, Issue:9

    Topics: Adult; Angioedema; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diagnosis, Differential; Female; Glomerulonephritis, Membranoproliferative; Humans; Lisinopril; Renal Dialysis; Tetrazoles; Valine; Valsartan

2005
[Angioedema and urticarial reaction induced by valsartan].
    Medicina clinica, 2000, Apr-22, Volume: 114, Issue:15

    Topics: Angioedema; Anti-Allergic Agents; Antihypertensive Agents; Antipruritics; Drug Eruptions; Female; Follow-Up Studies; Histamine H1 Antagonists; Humans; Loratadine; Middle Aged; Tetrazoles; Time Factors; Urticaria; Valine; Valsartan

2000
Can angiotensin II receptor blockers be used in patients who have developed a cough or angioedema as a result of taking an ACE inhibitor?
    Cleveland Clinic journal of medicine, 2001, Volume: 68, Issue:3

    Topics: Acrylates; Angioedema; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Black or African American; Clinical Trials as Topic; Cough; Female; Humans; Imidazoles; Irbesartan; Losartan; Male; Randomized Controlled Trials as Topic; Sex Factors; Telmisartan; Tetrazoles; Thiophenes; Valine; Valsartan

2001